Cargando…
Technology Development Through Pooling ARV Drug Patents: A Vision from China
Unaffordable prices still bar the end-users in China from accessing ARV drugs. Patent protection of ARV drugs has dramatically limited the availability of these lifesaving drugs to AIDS patients in China. The way Chinese government can go to breakthrough the ARV drug patents are suggested as: Make m...
Autores principales: | , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Bentham Open
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2831193/ https://www.ncbi.nlm.nih.gov/pubmed/20224635 http://dx.doi.org/10.2174/1874613601004020054 |
_version_ | 1782178223397797888 |
---|---|
author | Liu, Li Lu, Hongzhou |
author_facet | Liu, Li Lu, Hongzhou |
author_sort | Liu, Li |
collection | PubMed |
description | Unaffordable prices still bar the end-users in China from accessing ARV drugs. Patent protection of ARV drugs has dramatically limited the availability of these lifesaving drugs to AIDS patients in China. The way Chinese government can go to breakthrough the ARV drug patents are suggested as: Make more generic drugs available through compulsory licensing, impartment from other countries or building ARVs plants by partnerships between governments or generic drug companies. Do a thorough and detailed research on the patent application of ARV drugs to find out the loophole. Try patent pool to make AIDS medicines more affordable and appropriate for patients. |
format | Text |
id | pubmed-2831193 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | Bentham Open |
record_format | MEDLINE/PubMed |
spelling | pubmed-28311932010-03-11 Technology Development Through Pooling ARV Drug Patents: A Vision from China Liu, Li Lu, Hongzhou Open AIDS J Article Unaffordable prices still bar the end-users in China from accessing ARV drugs. Patent protection of ARV drugs has dramatically limited the availability of these lifesaving drugs to AIDS patients in China. The way Chinese government can go to breakthrough the ARV drug patents are suggested as: Make more generic drugs available through compulsory licensing, impartment from other countries or building ARVs plants by partnerships between governments or generic drug companies. Do a thorough and detailed research on the patent application of ARV drugs to find out the loophole. Try patent pool to make AIDS medicines more affordable and appropriate for patients. Bentham Open 2010-01-19 /pmc/articles/PMC2831193/ /pubmed/20224635 http://dx.doi.org/10.2174/1874613601004020054 Text en © Liu and Lu; Licensee Bentham Open. http://creativecommons.org/licenses/by-nc/3.0/ This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited. |
spellingShingle | Article Liu, Li Lu, Hongzhou Technology Development Through Pooling ARV Drug Patents: A Vision from China |
title | Technology Development Through Pooling ARV Drug Patents: A Vision from China |
title_full | Technology Development Through Pooling ARV Drug Patents: A Vision from China |
title_fullStr | Technology Development Through Pooling ARV Drug Patents: A Vision from China |
title_full_unstemmed | Technology Development Through Pooling ARV Drug Patents: A Vision from China |
title_short | Technology Development Through Pooling ARV Drug Patents: A Vision from China |
title_sort | technology development through pooling arv drug patents: a vision from china |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2831193/ https://www.ncbi.nlm.nih.gov/pubmed/20224635 http://dx.doi.org/10.2174/1874613601004020054 |
work_keys_str_mv | AT liuli technologydevelopmentthroughpoolingarvdrugpatentsavisionfromchina AT luhongzhou technologydevelopmentthroughpoolingarvdrugpatentsavisionfromchina |